Implementing the Assent Requirement for Research With Children
2 other identifiers
observational
800
1 country
1
Brief Summary
One of the principal safeguards mandated by the Federal Regulations governing clinical research with children is the assent requirement: children who are capable must provide an affirmative agreement to participate unless the research "holds out a prospect of direct benefit that is important to the health or well-being of the children and is available only in the context of the research" (46.408). Despite the importance of the assent requirement, the Federal regulations offer no guidelines on its implementation. In the present study, we propose to survey children and one of their parents in order to obtain information concerning children's role in making decisions concerning their participation in clinical research. Five elements of children's involvement in the decision-making process with respect to their participation in clinical research will be assessed: 1) receipt of information concerning the available options; 2) understanding of this information; 3) assessment of the available options; 4) expression of a preferred option; and 5) coordination with parental decision-making. Three groups will be enrolled: 1. Minor/Parent pairs where the minor is participating in, or is in follow-up for, a drug treatment research study for cancer 2. Minor/Parent pairs where the minor is participating in, or is in follow-up for, a drug treatment research study for asthma, and 3. Minor/Parent pairs where the minor is receiving on-going clinical care for asthma. Children 7-14 years of age will be enrolled. Total enrollment will be 400 subject pairs, approximately 150 in cancer research, 150 in asthma research and 100 involved in clinical care for asthma, with approximate balance between the sites. Two formalized survey instruments - research/clinical minor, research/clinical parent - will be developed in consultation with Research Triangle Institute (RTI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2001
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 16, 2001
CompletedFirst Submitted
Initial submission to the registry
January 19, 2005
CompletedFirst Posted
Study publicly available on registry
January 20, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2006
CompletedJuly 2, 2017
September 18, 2006
January 19, 2005
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Children in Research Studies:
- Currently enrolled in an ongoing medical intervention protocol, including follow-up, for cancer or asthma at one of the participating sites.
- Post initial visit.
- Enrolled within the previous year.
- Physically and cognitively able to participate in a 30 minute interview.
- Ability to understand and speak English.
- Age 7-14.
- Parents of Children in Research Studies:
- Parent of an eligible research child.
- Physically and cognitively able to participate in a 30 minute interview.
- Ability to understand and speak English.
- Children Receiving Clinical Care:
- Receiving clinical care at a clinic at one of the participating sites for cancer or asthma.
- Post initial visit.
- Physically and cognitively able to participate in a 30 minute interview.
- +6 more criteria
You may not qualify if:
- Inability to speak English.
- Inability to understand spoken English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center (CC)
Bethesda, Maryland, 20892, United States
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
January 19, 2005
First Posted
January 20, 2005
Study Start
November 16, 2001
Study Completion
September 18, 2006
Last Updated
July 2, 2017
Record last verified: 2006-09-18